These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Relationship between biological responsiveness to phorbol esters and receptor levels in GH4C1 rat pituitary cells. Jaken S; Tashjian AH; Blumberg PM Cancer Res; 1981 Dec; 41(12 Pt 1):4956-60. PubMed ID: 6272986 [TBL] [Abstract][Full Text] [Related]
10. Phorbol ester binding to chemotactically responding and nonresponding Walker 256 carcinosarcoma cells. Clarke PR; Varani J Cancer Res; 1984 Nov; 44(11):4967-71. PubMed ID: 6593115 [TBL] [Abstract][Full Text] [Related]
11. Analysis of human promyelocytic leukemia cell (HL60) variants insensitive to phorbol ester tumor promoters. Mascioli DW; Estensen RD Cancer Res; 1984 Aug; 44(8):3280-5. PubMed ID: 6331641 [TBL] [Abstract][Full Text] [Related]
12. Characterization of phorbol esters binding to K 562 cells. Louache F; Villeval JL; Pelicci PG; Rouis M; Titeux M; Henri A; Rochant H; Thomopoulos P; Testa U Anticancer Res; 1984; 4(1-2):33-9. PubMed ID: 6324650 [TBL] [Abstract][Full Text] [Related]
13. Down regulation of specific binding of [20-3H]phorbol 12,13-dibutyrate and phorbol ester-induced differentiation of human promyelocytic leukemia cells. Solanki V; Slaga TJ; Callaham M; Huberman E Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1722-5. PubMed ID: 6940185 [TBL] [Abstract][Full Text] [Related]
14. Binding of phorbol dibutyrate and epidermal growth factor to cultured human epidermal cells. Greenebaum E; Nicolaides M; Eisinger M; Vogel RH; Weinstein IB J Natl Cancer Inst; 1983 Mar; 70(3):435-41. PubMed ID: 6300498 [TBL] [Abstract][Full Text] [Related]
15. Characterization of phorbol ester receptors and their down-modulation in GH4C1 rat pituitary cells. Jaken S; Tashjian AH; Blumberg PM Cancer Res; 1981 Jun; 41(6):2175-81. PubMed ID: 6786733 [TBL] [Abstract][Full Text] [Related]
16. A phorbol ester-binding inhibitory factor from human placenta. Partial purification, characterization and biological effects. Hamel E; Yamasaki H; Tayot JL IARC Sci Publ; 1984; (56):157-64. PubMed ID: 6598799 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the growth inhibition induced by tumor-promoting phorbol esters and of their receptor binding in A549 human lung carcinoma cells. Gescher A; Reed DJ Cancer Res; 1985 Sep; 45(9):4315-21. PubMed ID: 3861245 [TBL] [Abstract][Full Text] [Related]
18. The role of phorbol ester receptor binding in responses to promoters by mouse and human cells. Colburn NH; Gindhart TD; Dalal B; Hegamyer GA Basic Life Sci; 1983; 24():189-200. PubMed ID: 6305327 [No Abstract] [Full Text] [Related]
19. Specific binding of [20-3H]12-deoxyphorbol 13-isobutyrate to phorbol ester receptor subclasses in mouse skin particulate preparations. Dunn JA; Blumberg PM Cancer Res; 1983 Oct; 43(10):4632-7. PubMed ID: 6309373 [TBL] [Abstract][Full Text] [Related]
20. Highly lipophilic phorbol esters as inhibitors of specific [3H]phorbol 12,13-dibutyrate binding. Sharkey NA; Blumberg PM Cancer Res; 1985 Jan; 45(1):19-24. PubMed ID: 3855281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]